Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Metro Brands gains 5% on posting healthy Q4 results; PAT up 24% YoY
In the March quarter (Q4FY26), Metro Brands reported a net profit of ₹118 crore, as compared to ₹95 crore a year ago, up 23.5 per cent
ITC Q4 Results 2026 LIVE: ITC share price rises ahead of earnings. All eyes on cigarette volumes, FMCG biz, dividend
ITC Q4 Results 2026 LIVE: ITC is expected to report muted performance during Q4FY26, with its cigarette business likely to remain under pressure due to the recent tax hikes. While FMCG segment is estimated to deliver healthy growth, its agri businesses is expected to post flat revenue growth.
BEL rises 2% on healthy Q4 show; brokerages stay cautiously optimistic
In the March quarter (Q4FY26), Bharat Electronics reported a net profit of ₹2,225.2 crore, as compared to ₹2,127.04 crore a year ago, up 4.6 per cent.
Q4 Results LIVE Updates: Sanghvi Movers shares surge over 12%; Jubilant Foodworks down 7%
Q4 Results LIVE Updates: ITC, Aurobindo Pharma, LIC, LG Electronics, Ashoka Buildcon, Bikaji Foods, Datamatics, Engineers India, GMM Pfaudler, Happy Forgings, Honasa Consumer, Ixigo, Nykaa, Page Industries, Ramco Cements, Max Healthcare, Prestige Estates, MTNL, Sun TV, Quick Heal, RCF, WeWork, VA Tech Wabag, are among the companies reporting their earnings today. The street will also react to numbers reported by Whirlpool, Apollo Hospitals, Sammaan Capital, JK Lakshmi Cement, Lenskart, Ola Electric and others. Watch this space for all the LIVE earnings updates.
Stocks to Watch for May 21: Aditya Birla Capital, Dr Reddy's Lab, Jubilant Food, Bosch India and more
From Dr Reddy's Laboratories announcing the launch of its oral semaglutide biosimilar in India under the brand name Obeda to Whirlpool of India Ltd reporting a 32.7% year-on-year decline in net profit Q4, here are some stocks to track ahead of Thursday trading session.
Aditya Birla Grp to invest Rs 3,080 cr in fin services arm, IFC to pump Rs 920 cr
Aditya Birla Capital is raising Rs 4,000 crore for future growth. The Aditya Birla Group will invest Rs 3,080 crore and IFC will invest Rs 980 crore. This capital infusion will fund growth objectives, including lending and investments. The company aims to expand access to financing for entrepreneurs and businesses. This move supports India's economic transformation and financial inclusion.
Aditya Birla Capital Approves Rs 4,000-Cr Share Issuance; Promoter Grasim Leads Infusion
Aditya Birla Capital plans to raise Rs 2,880 crore from promoter Grasim Industries.
Aditya Birla Capital raises ₹4,000 crore to fund growth, confirms CNBC-TV18 Newsbreak
The company said the proceeds from the issue will be used for growth objectives, augmentation of the capital base, funding requirements for the lending business and general corporate purposes, including investments in subsidiaries, joint ventures and associates.
Hindalco share price jumps 4% after Novelis posts Q4 earnings 2026; check results date for the Aditya Birla Group stock
Hindalco Industries shares rose 4% to ₹1,089.60 after Novelis reported a quarterly net loss of $84 million. Despite fire-related impacts, quarterly net sales increased 4% to $4.8 billion, driven by higher aluminium prices.
Sensex Rejig: Trent likely exclusion; Could be replaced by either of these two names
Two names remain the key contenders to replace Trent in the Sensex as part of the rejig. One is Aditya Birla Group's Hindalco Industries, and the other is Shriram Finance.
Zydus Lifesciences shares gain 7%, hit 52-week high on healthy Q4 show
In the March quarter (Q4FY26), Zydus Lifesciences reported a net profit of ₹1,272.5 crore, as compared to ₹1,170.9 crore a year ago, up 8.7 per cent
Mankind Pharma Q4 revenue rises 12%; chronic therapies drive margin expansion
Mankind Pharma reported strong fourth-quarter operating performance driven by healthy domestic demand, chronic therapy growth and improved margins, while international business growth remained muted amid geopolitical challenges.